Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)
Clinical trial NCT06090461 · COMPLETED
Trial details
- NCT number
- NCT06090461
- Sponsor
- Currax Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-09-01
- Primary completion
- 2022-12-01
- Enrollment
- 31889
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.